You are currently viewing POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) – Interim analysis

POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) – Interim analysis

EBC - ON DEMAND

POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) – Interim analysis

European Bifurcation Club 2014 – EBC 2014 – Bordeaux, France

BALTON

POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) – Interim analysis

AuthorRobert J. Gil, MD, PhD, Mossakowski Medical Research Centre, Polish Academy of Sciences, Invasive Cardiology Dept., Central Hospital of the Internal Affairs Ministry, Warsaw, Poland

 

CONCLUSION

Interim analysis has showed that dedicated paclitaxel eluting bifurcation stent provides satisfactory results which seem to demonstrate equivalence in hard end points (death, MI, strokes). The completion of the POLBOS Study will show possible differences (or equivalence) of secondary end-points.

 

Download here

Leave a Reply